Intermediate density lipoprotein: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Intermediate density lipoprotein}} | {{Intermediate density lipoprotein}} | ||
{{CMG | {{CMG}} | ||
== [[Intermediate density lipoprotein overview|Overview]] == | == [[Intermediate density lipoprotein overview|Overview]] == | ||
| Line 14: | Line 14: | ||
== Clinical Correlation== | == Clinical Correlation== | ||
===[[High | ===[[High IDL]]=== | ||
[[High | [[High IDL epidemiology and demographics|Epidemiology and Demographics]] | [[High IDL pathophysiology|Pathophysiology]] | [[High IDL causes|Causes]] | [[High IDL diseases|Diseases]] | [[High IDL prognosis and complications|Prognosis and Complications]] | ||
===[[Low | ===[[Low IDL]]=== | ||
[[Low | [[Low IDL epidemiology and demographics|Epidemiology and Demographics]] | [[Low IDL pathophysiology|Pathophysiology]] | [[Low IDL causes|Causes]] | [[Low IDL diseases|Diseases]] | [[Low IDL prognosis and complications|Prognosis and Complications]] | ||
== Treatment == | == Treatment == | ||
Latest revision as of 17:10, 12 September 2013
|
Intermediate Density Lipoprotein Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Intermediate density lipoprotein On the Web |
|
American Roentgen Ray Society Images of Intermediate density lipoprotein |
|
Directions to Hospitals Treating Intermediate density lipoprotein |
|
Risk calculators and risk factors for Intermediate density lipoprotein |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High IDL
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low IDL
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies